Quick Answer
Pyxis Oncology, Inc. reported Net Income of -$79.62 million for fiscal year 2025.
Pyxis Oncology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$79.62M | -3.0% |
| 2024 | -$77.33M | -4.8% |
| 2023 | -$73.79M | +38.9% |
| 2022 | -$120.72M | -58.9% |
| 2021 | -$75.97M | -492.3% |
| 2020 | -$12.83M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$22.00M | -3.8% | -19.9% |
| June 30, 2025 | -$18.35M | -6.1% | +13.3% |
| March 31, 2025 | -$21.16M | -549.8% | +0.2% |
| September 30, 2024 | -$21.20M | +8.0% | -22.6% |
| June 30, 2024 | -$17.30M | -8.8% | -431.4% |
| March 31, 2024 | -$3.26M | +83.1% | +85.9% |
| September 30, 2023 | -$23.05M | +16.7% | -45.0% |
| June 30, 2023 | -$15.90M | +37.8% | +17.4% |
- Pyxis Oncology, Inc. showed a decrease of -3.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Pyxis Oncology, Inc.’s net income has declined by 520.7% (from -$12.83 million to -$79.62 million).
- The most recent figure is from Pyxis Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: